Although only some glucagon-like peptide-1 receptor agonists (GLP-1 RAs) include warnings and precautions regarding acute gallbladder disease, there are reported cases of acute cholecystitis among patients treated with GLP-1 RA products that did not have such warnings and precautions in the prescribing information approved by the United States (US) Food...
Diabetes drugs linked to risk of acute gallbladder disease
Heather Mason
 | Â
Medical News
 | Â
02 September 2022
Register or log in to read more
Registration is free and easy, giving you complete access to all Univadis content.
Create a Free Account I have an account
         Â